GeneBioTech Co. Ltd
Genebiotech Co., Ltd., a specialized fermentation company, researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food, medicine, etc. It offers functional feed ingredients and additives, as well as veterinary medicines. The company was founded in 1984 and is headquartered in Gongju, South Korea.
Market Cap & Net Worth: GeneBioTech Co. Ltd (086060)
GeneBioTech Co. Ltd (KQ:086060) has a market capitalization of $29.90 Million (₩43.78 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #25092 globally and #1513 in its home market, demonstrating a 1.95% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GeneBioTech Co. Ltd's stock price ₩5230.00 by its total outstanding shares 8370460 (8.37 Million).
GeneBioTech Co. Ltd Market Cap History: 2015 to 2026
GeneBioTech Co. Ltd's market capitalization history from 2015 to 2026. Data shows growth from $26.63 Million to $29.90 Million (3.62% CAGR).
Index Memberships
GeneBioTech Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$166.01 Billion | 0.01% | #778 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$166.01 Billion | 0.01% | #778 of 1384 |
Weight: GeneBioTech Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GeneBioTech Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GeneBioTech Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
GeneBioTech Co. Ltd's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
GeneBioTech Co. Ltd's market cap is 0.01 times its annual earnings
0.19x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $26.63 Million | $52.26 Billion | $1.71 Billion | 0.00x | 0.02x |
| 2016 | $31.38 Million | $55.63 Billion | $2.73 Billion | 0.00x | 0.01x |
| 2017 | $26.25 Million | $55.53 Billion | $2.09 Billion | 0.00x | 0.01x |
| 2018 | $22.85 Million | $62.81 Billion | $2.68 Billion | 0.00x | 0.01x |
| 2019 | $31.77 Million | $58.24 Billion | $846.78 Million | 0.00x | 0.04x |
| 2020 | $32.68 Million | $59.12 Billion | -$2.34 Billion | 0.00x | N/A |
| 2021 | $29.96 Million | $62.81 Billion | -$484.40 Million | 0.00x | N/A |
| 2022 | $22.81 Million | $82.76 Billion | $1.52 Billion | 0.00x | 0.01x |
| 2023 | $24.92 Million | $79.48 Billion | $2.59 Billion | 0.00x | 0.01x |
| 2024 | $18.81 Million | $82.96 Billion | $2.87 Billion | 0.00x | 0.01x |
Competitor Companies of 086060 by Market Capitalization
Companies near GeneBioTech Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to GeneBioTech Co. Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3469 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #5585 globally with a market cap of $1.61 Billion USD ( ₩2.36 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7048 globally with a market cap of $1.07 Billion USD ( ₩1.56 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7477 globally with a market cap of $962.14 Million USD ( ₩1.41 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3469 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩730000.00 |
| #5585 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.61 Billion | ₩113500.00 |
| #7048 | ST Pharm Co.Ltd | KQ:237690 | $1.07 Billion | ₩155100.00 |
| #7477 | Oscotec Inc | KQ:039200 | $962.14 Million | ₩59300.00 |
GeneBioTech Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, GeneBioTech Co. Ltd's market cap moved from $26.63 Million to $ 29.90 Million, with a yearly change of 3.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩29.90 Million | +30.42% |
| 2025 | ₩22.92 Million | +21.88% |
| 2024 | ₩18.81 Million | -24.54% |
| 2023 | ₩24.92 Million | +9.27% |
| 2022 | ₩22.81 Million | -23.85% |
| 2021 | ₩29.96 Million | -8.34% |
| 2020 | ₩32.68 Million | +2.87% |
| 2019 | ₩31.77 Million | +39.02% |
| 2018 | ₩22.85 Million | -12.94% |
| 2017 | ₩26.25 Million | -16.34% |
| 2016 | ₩31.38 Million | +17.81% |
| 2015 | ₩26.63 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of GeneBioTech Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.90 Million USD |
| MoneyControl | $29.90 Million USD |
| MarketWatch | $29.90 Million USD |
| marketcap.company | $29.90 Million USD |
| Reuters | $29.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.